LEADER 04068nam  22005775  450 
001 9910254556003321
005 20200630035614.0
010   $a3-319-30964-1
024 7 $a10.1007/978-3-319-30964-4
035   $a(CKB)3710000000718118
035   $a(DE-He213)978-3-319-30964-4
035   $a(MiAaPQ)EBC4533863
035   $a(PPN)19407921X
035   $a(EXLCZ)993710000000718118
100   $a20160528d2016      u|             0
101 0 $aeng
135   $aurnn|008mamaa
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aControlled Substance Management in Chronic Pain$b[electronic resource] $eA Balanced Approach /$fedited by Peter S. Staats, Sanford M. Silverman
205   $a1st ed. 2016.
210  1$aCham :$cSpringer International Publishing :$cImprint: Springer,$d2016.
215   $a1 online resource (XII, 323 p. 32 illus., 18 illus. in color.) 
311   $a3-319-30962-5 
320   $aIncludes bibliographical references at the end of each chapters and index.
327   $a1 Scope of the pain problem -- 2 Scope of the problem: Intersection of chronic pain and addiction -- 3 Evidence-based treatment for chronic pain with opioids -- 4 Opioid pharmacology -- 5 Pharmacokinetics -- 6 Benzodiazepines, Alcohol and Stimulant Use in Combination with Opioid Use -- 7 Marijuana and cannabinoids for pain -- 8 Adjuvant agents in chronic pain therapy -- 9 Complications of opioid therapy -- 10 Risk mitigation strategies -- 11 Naloxone Treatment of Opioid Overdose -- 12 From Patient Evaluation to Opioid Overdose Prevention: Ten Steps to Make the Law Work for You and Your Patients -- 13 Treating the difficult patient -- 14 Controlled Substance Management: Exit Strategies for the Pain Practitioner -- 15 Alternatives to opiates in the management of non-cancer related pain -- Appendix A: American Society of Interventional Pain Physicians (ASIPP) Guidelines for Responsible Opioid Prescribing in Chronic Non-Cancer Pain -- Appendix B: Sample Opioid Agreement/Informed Consent -- Appendix C: Opioid Risk Tool -- Appendix D: Screener and Opioid Assessment for Patients with Pain-Revised (SOAPP®-R) -- Appendix E: McGill Pain Questionnaire.
330   $aThis comprehensive guide covers prescribing controlled substances for patients with acute or chronic pain and provides a balanced discussion on appropriate treatment, addiction, safety and complications. Chapters feature evidence-based strategies and clinical modalities that address diagnostic challenges, treatment guidance, alternatives to opioid management and the significant legal risks within the current regulatory environment. Authored by leaders in pain medicine, physicians and appropriate health care professionals will find Controlled Substance Management in Chronic Pain to be an indispensable resource. .
606   $aPain medicine
606   $aPharmacotherapy
606   $aPharmacy management
606   $aPrimary care (Medicine)
606   $aPain Medicine$3https://scigraph.springernature.com/ontologies/product-market-codes/H47003
606   $aPharmacotherapy$3https://scigraph.springernature.com/ontologies/product-market-codes/H69000
606   $aPharmacoeconomics and Health Outcomes$3https://scigraph.springernature.com/ontologies/product-market-codes/H69020
606   $aPrimary Care Medicine$3https://scigraph.springernature.com/ontologies/product-market-codes/H51000
615  0$aPain medicine.
615  0$aPharmacotherapy.
615  0$aPharmacy management.
615  0$aPrimary care (Medicine).
615 14$aPain Medicine.
615 24$aPharmacotherapy.
615 24$aPharmacoeconomics and Health Outcomes.
615 24$aPrimary Care Medicine.
676   $a616.0472
702   $aStaats$b Peter S$4edt$4http://id.loc.gov/vocabulary/relators/edt
702   $aSilverman$b Sanford M$4edt$4http://id.loc.gov/vocabulary/relators/edt
906   $aBOOK
912   $a9910254556003321
996   $aControlled Substance Management in Chronic Pain$92529653
997   $aUNINA